Berthon C - Search Results

1

Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group.

Janin M, Mylonas E, Saada V, Micol JB, Renneville A, Quivoron C, Koscielny S, Scourzic L, Forget S, Pautas C, Caillot D, Preudhomme C, Dombret H, Berthon C, Barouki R, Rabier D, Auger N, Griscelli F, Chachaty E, Leclercq E, Courtier MH, Bennaceur-Griscelli A, Solary E, Bernard OA, Penard-Lacronique V, Ottolenghi C, de Botton S. Janin M, et al. Among authors: berthon c. J Clin Oncol. 2014 Feb 1;32(4):297-305. doi: 10.1200/JCO.2013.50.2047. Epub 2013 Dec 16. J Clin Oncol. 2014. PMID: 24344214

2

A new combination of monocytic scores to support diagnosis of chronic myelomonocytic leukemia according to novel classifications.

Podvin B, Soenen V, Dumezy F, Herlem J, Berthon C, Guermouche H, Thibaud V, Pascal L, Duployez N, Charpentier A. Podvin B, et al. Among authors: berthon c. Int J Lab Hematol. 2023 Oct;45(5):791-794. doi: 10.1111/ijlh.14067. Epub 2023 Mar 26. Int J Lab Hematol. 2023. PMID: 36967295 No abstract available.

3

Successful bridging to cell therapy for relapsed/refractory acute lymphoblastic leukaemia with a combination of venetoclax and PEG-asparaginase.

Goursaud L, Berthon C, Quesnel B. Goursaud L, et al. Among authors: berthon c. Br J Haematol. 2023 Feb;200(4):e37-e39. doi: 10.1111/bjh.18595. Epub 2022 Dec 5. Br J Haematol. 2023. PMID: 36470305 No abstract available.

4

Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma.

Depil S, Leleu X, Micol JB, Berthon C, Laï JL, Bauters F, Quesnel B, Facon T. Depil S, et al. Among authors: berthon c. Leuk Lymphoma. 2004 Dec;45(12):2481-4. doi: 10.1080/10428190412331283224. Leuk Lymphoma. 2004. PMID: 15621764

5

[Thalidomide: mechanisms of action and new insights in hematology].

Leleu X, Micol JB, Guieze R, Berthon C, Kuhnovsky F, Terriou L, Moreau AS, Yakoub-Agha I, Bauters F, Facon T. Leleu X, et al. Among authors: berthon c. Rev Med Interne. 2005 Feb;26(2):119-27. doi: 10.1016/j.revmed.2004.06.017. Rev Med Interne. 2005. PMID: 15710258 Review. French.

6

Enteral feeding and early outcomes of patients undergoing allogeneic stem cell transplantation following myeloablative conditioning.

Seguy D, Berthon C, Micol JB, Darré S, Dalle JH, Neuville S, Bauters F, Jouet JP, Yakoub-Agha I. Seguy D, et al. Among authors: berthon c. Transplantation. 2006 Sep 27;82(6):835-9. doi: 10.1097/01.tp.0000229419.73428.ff. Transplantation. 2006. PMID: 17006332

7

Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature review.

Micol JB, Berthon C, Tricot S, Terriou L, Darré S, Cracco P, Boulanger F, Bauters F, Jouet JP, Yakoub-Agha I. Micol JB, et al. Among authors: berthon c. Leuk Lymphoma. 2007 Feb;48(2):321-9. doi: 10.1080/10428190601059688. Leuk Lymphoma. 2007. PMID: 17325892

8

Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia.

Renneville A, Boissel N, Helevaut N, Nibourel O, Terré C, Pautas C, Gardin C, Thomas X, Turlure P, Reman O, Berthon C, Dombret H, Castaigne S, Preudhomme C. Renneville A, et al. Among authors: berthon c. Leukemia. 2011 Dec;25(12):1918-21. doi: 10.1038/leu.2011.173. Epub 2011 Jul 15. Leukemia. 2011. PMID: 21760594 No abstract available.

9

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French association.

Farhat H, Reman O, Raffoux E, Berthon C, Pautas C, Kammoun L, Chantepie S, Gardin C, Rousselot P, Chevret S, Dombret H, Castaigne S. Farhat H, et al. Among authors: berthon c. Am J Hematol. 2012 Jan;87(1):62-5. doi: 10.1002/ajh.22201. Epub 2011 Nov 10. Am J Hematol. 2012. PMID: 22072535 Free article. Clinical Trial.

10

Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.

Abdelhamid E, Preudhomme C, Helevaut N, Nibourel O, Gardin C, Rousselot P, Castaigne S, Gruson B, Berthon C, Soua Z, Renneville A. Abdelhamid E, et al. Among authors: berthon c. Leuk Res. 2012 Mar;36(3):316-23. doi: 10.1016/j.leukres.2011.11.002. Epub 2011 Nov 29. Leuk Res. 2012. PMID: 22129478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page